Saeed S. Alamri, Abdullah A. Jammah, Saleh A Alkhaldi, Abdulkarim A. AlKharashi, Adel A. Aljatham
{"title":"视盘浸润是急性淋巴细胞白血病复发的首发症状:病例报告","authors":"Saeed S. Alamri, Abdullah A. Jammah, Saleh A Alkhaldi, Abdulkarim A. AlKharashi, Adel A. Aljatham","doi":"10.2174/0118743641302926240520102811","DOIUrl":null,"url":null,"abstract":"\n \n This case report presents a unique manifestation of relapsed B-cell Acute Lymphoblastic Leukemia (ALL) involving the ocular system. This study contributes to the scientific literature by providing documented evidence of ocular complications, specifically central retinal vein occlusion (CRVO), central retinal artery occlusion (CRAO), and optic nerve infiltration, in a patient experiencing the relapse of ALL.\n \n \n \n A 17-year-old male with a history of B-cell ALL presented with decreased vision in the right eye. Clinical examination revealed CRVO, CRAO, and optic nerve infiltration by leukemic cells. Imaging studies confirmed the presence of a retro-orbital mass and subretinal choroidal involvement. Bone marrow aspiration and biopsy confirmed relapsed of ALL. The patient was subsequently referred for further management.\n \n \n \n This case highlights the importance of considering ocular manifestations, such as CRVO, CRAO, and optic nerve infiltration, in patients with relapsed ALL. Ophthalmological evaluation should be included in the follow-up and management of ALL patients to detect and manage ocular complications promptly. Early recognition and treatment of ocular manifestations can improve outcomes and quality of life for these patients.\n","PeriodicalId":512318,"journal":{"name":"The Open Ophthalmology Journal","volume":"11 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Optic Disc Infiltration as a First Sign of Acute Lymphoblastic Leukemia Relapse: A Case Report\",\"authors\":\"Saeed S. Alamri, Abdullah A. Jammah, Saleh A Alkhaldi, Abdulkarim A. AlKharashi, Adel A. Aljatham\",\"doi\":\"10.2174/0118743641302926240520102811\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n \\n This case report presents a unique manifestation of relapsed B-cell Acute Lymphoblastic Leukemia (ALL) involving the ocular system. This study contributes to the scientific literature by providing documented evidence of ocular complications, specifically central retinal vein occlusion (CRVO), central retinal artery occlusion (CRAO), and optic nerve infiltration, in a patient experiencing the relapse of ALL.\\n \\n \\n \\n A 17-year-old male with a history of B-cell ALL presented with decreased vision in the right eye. Clinical examination revealed CRVO, CRAO, and optic nerve infiltration by leukemic cells. Imaging studies confirmed the presence of a retro-orbital mass and subretinal choroidal involvement. Bone marrow aspiration and biopsy confirmed relapsed of ALL. The patient was subsequently referred for further management.\\n \\n \\n \\n This case highlights the importance of considering ocular manifestations, such as CRVO, CRAO, and optic nerve infiltration, in patients with relapsed ALL. Ophthalmological evaluation should be included in the follow-up and management of ALL patients to detect and manage ocular complications promptly. Early recognition and treatment of ocular manifestations can improve outcomes and quality of life for these patients.\\n\",\"PeriodicalId\":512318,\"journal\":{\"name\":\"The Open Ophthalmology Journal\",\"volume\":\"11 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Open Ophthalmology Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0118743641302926240520102811\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Open Ophthalmology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0118743641302926240520102811","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
本病例报告介绍了复发性B细胞急性淋巴细胞白血病(ALL)涉及眼部系统的一种独特表现。本研究提供了一名急性淋巴细胞白血病复发患者眼部并发症的记录证据,特别是视网膜中央静脉闭塞(CRVO)、视网膜中央动脉闭塞(CRAO)和视神经浸润,为科学文献做出了贡献。 一名曾患 B 细胞 ALL 的 17 岁男性患者出现右眼视力下降。临床检查发现他患有CRVO、CRAO和视神经白血病细胞浸润。影像学检查证实存在眶后肿块和视网膜下脉络膜受累。骨髓抽吸和活检证实了 ALL 复发。患者随后被转诊接受进一步治疗。 本病例强调了考虑ALL复发患者眼部表现(如CRVO、CRAO和视神经浸润)的重要性。眼科评估应纳入ALL患者的随访和管理中,以便及时发现和处理眼部并发症。早期识别和治疗眼部表现可以改善这些患者的预后和生活质量。
Optic Disc Infiltration as a First Sign of Acute Lymphoblastic Leukemia Relapse: A Case Report
This case report presents a unique manifestation of relapsed B-cell Acute Lymphoblastic Leukemia (ALL) involving the ocular system. This study contributes to the scientific literature by providing documented evidence of ocular complications, specifically central retinal vein occlusion (CRVO), central retinal artery occlusion (CRAO), and optic nerve infiltration, in a patient experiencing the relapse of ALL.
A 17-year-old male with a history of B-cell ALL presented with decreased vision in the right eye. Clinical examination revealed CRVO, CRAO, and optic nerve infiltration by leukemic cells. Imaging studies confirmed the presence of a retro-orbital mass and subretinal choroidal involvement. Bone marrow aspiration and biopsy confirmed relapsed of ALL. The patient was subsequently referred for further management.
This case highlights the importance of considering ocular manifestations, such as CRVO, CRAO, and optic nerve infiltration, in patients with relapsed ALL. Ophthalmological evaluation should be included in the follow-up and management of ALL patients to detect and manage ocular complications promptly. Early recognition and treatment of ocular manifestations can improve outcomes and quality of life for these patients.